Cargando…

Polytherapy and drug interactions in elderly

There is an increase in population of elderly above the age of 65. As age advances, more diseases develop resulting in use of more medications. Physiological changes, alterations in homeostatic regulation and diseases modify pharmacokinetics and drug response in older patients. The risk for drug int...

Descripción completa

Detalles Bibliográficos
Autor principal: Gujjarlamudi, Hima Bindu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5051228/
https://www.ncbi.nlm.nih.gov/pubmed/27721636
http://dx.doi.org/10.4103/0976-7800.191021
_version_ 1782458042669858816
author Gujjarlamudi, Hima Bindu
author_facet Gujjarlamudi, Hima Bindu
author_sort Gujjarlamudi, Hima Bindu
collection PubMed
description There is an increase in population of elderly above the age of 65. As age advances, more diseases develop resulting in use of more medications. Physiological changes, alterations in homeostatic regulation and diseases modify pharmacokinetics and drug response in older patients. The risk for drug interactions and drug-related problems increases along with multiple medications. Periodic evaluation of the patients’ drug regimen is essential to minimize polytherapy. Clinicians must be alert to the use of herbal and dietary supplements as they are prone to drug-drug interactions. This article focuses on the possible pharmacokinetic, pharmacodynamic, and herbal drug interactions occurring in the elderly.
format Online
Article
Text
id pubmed-5051228
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-50512282016-10-07 Polytherapy and drug interactions in elderly Gujjarlamudi, Hima Bindu J Midlife Health Review Article There is an increase in population of elderly above the age of 65. As age advances, more diseases develop resulting in use of more medications. Physiological changes, alterations in homeostatic regulation and diseases modify pharmacokinetics and drug response in older patients. The risk for drug interactions and drug-related problems increases along with multiple medications. Periodic evaluation of the patients’ drug regimen is essential to minimize polytherapy. Clinicians must be alert to the use of herbal and dietary supplements as they are prone to drug-drug interactions. This article focuses on the possible pharmacokinetic, pharmacodynamic, and herbal drug interactions occurring in the elderly. Medknow Publications & Media Pvt Ltd 2016 /pmc/articles/PMC5051228/ /pubmed/27721636 http://dx.doi.org/10.4103/0976-7800.191021 Text en Copyright: © 2016 Journal of Mid-life Health http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
spellingShingle Review Article
Gujjarlamudi, Hima Bindu
Polytherapy and drug interactions in elderly
title Polytherapy and drug interactions in elderly
title_full Polytherapy and drug interactions in elderly
title_fullStr Polytherapy and drug interactions in elderly
title_full_unstemmed Polytherapy and drug interactions in elderly
title_short Polytherapy and drug interactions in elderly
title_sort polytherapy and drug interactions in elderly
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5051228/
https://www.ncbi.nlm.nih.gov/pubmed/27721636
http://dx.doi.org/10.4103/0976-7800.191021
work_keys_str_mv AT gujjarlamudihimabindu polytherapyanddruginteractionsinelderly